Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07832643 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Primary Allergy and Its Impact on the Occurrence of Respiratory Distress in Infants at 12 Months of Age

Study acronym: AIRE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
The number of people with allergies has been steadily increasing over the years. Symptoms in infants, such as bronchiolitis, gastroesophageal reflux, eczema, or atopic dermatitis, can be early warning signs of allergies in childhood. Given the rising prevalence of allergies and the number of children affected by bronchiolitis, it is worth investigating whether the presence of allergies in parents is associated with a higher likelihood of developing bronchiolitis in childhood. To determine the incidence of respiratory distress in infants with at least one allergic parent compared to infants with no allergic parents at 12 months of age. Parents will be asked to complete a questionnaire at two time points: at 6 months and at 12 months of age. The incidence of bronchiolitis during the first year of life is higher among infants with at least one parent who has allergies.
Trial Details
NCT Number NCT07832643
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Conditions
(from sponsor)
Allergy, Respiratory Distress, Atopic Manifestations, Immediate Postnatal Parameters
Related terms Dyspnea, Hypersensitivity
Enrollment 508 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov